Treace Medical Concepts, Inc. TMCI Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$61.04M-15.2% | -$59M-5.8% | -$50.11M+18.6% | -$49.18M+22.8% | -$52.99M+3.2% | ||
| $9.06M+1.0% | $10.62M+26.2% | $10.05M+26.4% | $9.43M+28.2% | $8.97M+41.5% | ||
| $33.16M+4.0% | $33.82M+10.5% | $34.82M+24.7% | $34.73M+37.7% | $31.89M+44.5% | ||
| $480K+61.6% | $292K-2.0% | $298K+0.3% | $297K-0.3% | $297K-0.3% | ||
| —— | —— | —— | —— | —— | ||
| -$306K-107% | $2.09M-63.2% | $9.76M+409% | $6M+574% | $4.22M-20.0% | ||
| -$1.57M— | -$3.22M— | —— | —— | —— | ||
| $314K+104% | -$3.8M-189% | -$2.55M-126% | $1.89M-81.0% | -$7.93M-149% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $695K— | $406K+488% | ||
| —— | —— | —— | —— | -$47K+61.5% | ||
| -$3.28M— | -$3.21M— | -$4.71M— | —— | —— | ||
| -$12.93M+49.8% | -$15.97M+57.0% | -$12.15M+63.1% | -$14.9M+51.4% | -$25.75M-2.7% | ||
| $13.04M+16.3% | $13.52M+16.6% | $14.19M+31.8% | $14.25M+24.9% | $11.21M-19.4% | ||
| $41.55M-28.3% | $40.57M-43.3% | $53.58M-35.2% | $73.12M-5.8% | $57.96M-41.5% | ||
| $7.33M-75.3% | $13.25M-62.5% | $7.01M— | $4.03M— | $29.72M— | ||
| $518K+4.6% | $546K+27.6% | $533K-2.9% | $300K-57.1% | $495K-68.5% | ||
| $708K— | $902K— | $858K— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| $1.78M+2,727% | $2.09M+1,204% | $731K+144% | $739K+64.2% | $63K-95.2% | ||
| —— | —— | -$4.42M— | -$10.13M— | $4.04M— | ||
| $4.63M-5.0% | $5M+0.8% | $4.98M-1.2% | $4.96M-2.6% | $4.87M-6.4% | ||
| $41K-95.4% | $123K-89.3% | $346K-73.2% | $574K-59.8% | $887K-38.6% | ||
| $480K+61.6% | $292K-2.0% | $298K+0.3% | $297K-0.3% | $297K-0.3% | ||
| —— | $2.74M— | $2.05M— | $1.37M— | $684.25K— | ||
| -$3.28M— | -$3.21M— | -$4.71M— | —— | —— | ||
| —— | —— | —— | —— | -$5.05M— | ||
| $2.22M— | $2.22M— | $3.43M— | —— | —— | ||
| -$1.61M-153% | -$1.21M-125% | -$1.11M-401% | -$598K-66.6% | -$635K-115% | ||
| —— | —— | —— | —— | $0— | ||
| $1.38M— | $916K— | $507K— | $98K— | —— | ||
| —— | $56.32M— | $42.24M— | $28.16M— | $14.08M— | ||
| -$3.28M— | -$3.21M— | -$4.71M— | —— | —— | ||
| —— | $0— | $0+100% | $0+100% | $0+100% | ||
| $1.56M+3,367% | $1.11M— | $752K— | $228K— | $45K— | ||
| -$25.96M+29.7% | -$29.49M+39.5% | -$26.34M+39.0% | -$29.15M+29.8% | -$36.96M+3.9% | ||
| -$25.96M+29.7% | -$29.49M+39.5% | -$26.34M+39.0% | -$29.15M+29.8% | -$36.96M+3.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Treace Medical Concepts, Inc. generate?
- Treace Medical Concepts, Inc. (TMCI) generated -$12.9M in operating cash flow over the trailing twelve months.
- What is Treace Medical Concepts, Inc.'s free cash flow?
- After $13.0M of capital expenditures, Treace Medical Concepts, Inc.'s free cash flow was -$26.0M over the trailing twelve months, up 29.8% year over year.
- Where does Treace Medical Concepts, Inc.'s cash flow data come from?
- Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
